IRIS
ANDREUCCI, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.915
AS - Asia 3.964
EU - Europa 1.814
SA - Sud America 1.153
AF - Africa 105
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 11.977
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.722
SG - Singapore 1.791
BR - Brasile 899
IT - Italia 860
CN - Cina 794
VN - Vietnam 558
IN - India 332
DE - Germania 203
GB - Regno Unito 190
HK - Hong Kong 116
BD - Bangladesh 114
CA - Canada 105
SE - Svezia 105
AR - Argentina 100
FI - Finlandia 89
NL - Olanda 63
UA - Ucraina 62
MX - Messico 57
ID - Indonesia 46
FR - Francia 45
EC - Ecuador 44
ZA - Sudafrica 39
IQ - Iraq 38
RU - Federazione Russa 32
CO - Colombia 31
ES - Italia 29
JP - Giappone 28
RO - Romania 28
CL - Cile 27
PL - Polonia 24
TR - Turchia 18
UZ - Uzbekistan 18
EG - Egitto 16
IR - Iran 15
PK - Pakistan 15
PY - Paraguay 15
AU - Australia 13
VE - Venezuela 13
AT - Austria 12
MA - Marocco 12
TN - Tunisia 12
GR - Grecia 11
SA - Arabia Saudita 11
PE - Perù 10
CZ - Repubblica Ceca 9
KE - Kenya 9
UY - Uruguay 9
JO - Giordania 7
TH - Thailandia 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
KZ - Kazakistan 6
LT - Lituania 6
RS - Serbia 6
TW - Taiwan 6
KR - Corea 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
BO - Bolivia 4
EU - Europa 4
LB - Libano 4
MY - Malesia 4
SI - Slovenia 4
SV - El Salvador 4
AO - Angola 3
BN - Brunei Darussalam 3
ET - Etiopia 3
HN - Honduras 3
IE - Irlanda 3
KG - Kirghizistan 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
PR - Porto Rico 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
CY - Cipro 2
DZ - Algeria 2
EE - Estonia 2
IL - Israele 2
LU - Lussemburgo 2
NP - Nepal 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AQ - Antartide 1
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
Totale 11.959
Salva come PNG Salva come JPEG
Città #
San Jose 924
Singapore 629
Dallas 516
Ashburn 416
Chandler 378
Santa Clara 312
Bengaluru 262
Hefei 261
Milan 231
Ho Chi Minh City 210
Lawrence 191
Princeton 191
London 130
Chicago 129
Munich 128
Beijing 118
Hanoi 116
Wilmington 115
Hong Kong 107
São Paulo 77
Turku 62
Catanzaro 58
Los Angeles 58
Des Moines 56
Boardman 55
New York 54
Ottawa 54
Rome 31
Rio de Janeiro 29
Shanghai 27
Helsinki 26
Naples 26
Haiphong 25
Amsterdam 24
Boydton 23
Brooklyn 23
Norwalk 23
Palermo 23
Da Nang 20
Thái Bình 20
Bari 19
Redwood City 18
Johannesburg 17
San Francisco 17
Tashkent 17
Baghdad 16
Boston 16
Guayaquil 16
Orem 16
Tokyo 16
Warsaw 16
Chennai 15
Council Bluffs 15
Guarulhos 15
Mexico City 15
Biên Hòa 14
Florence 14
Quito 14
Redmond 14
Ninh Bình 13
Porto Alegre 13
Guangzhou 12
Montreal 12
Toronto 12
Verona 12
Crotone 11
Dhaka 11
Hanover 11
Manchester 11
Phoenix 11
Seattle 11
Timisoara 11
Assago 10
Atlanta 10
Bologna 10
Buffalo 10
Curitiba 10
Mumbai 10
Belo Horizonte 9
Brasília 9
Columbus 9
Hải Dương 9
Medellín 9
Nairobi 9
Pescara 9
Pune 9
Sydney 9
The Dalles 9
Campinas 8
Erbil 8
Jakarta 8
Lima 8
Manaus 8
Salvador 8
Shenzhen 8
Shibin al Kawm 8
Stockholm 8
Wuhan 8
Buenos Aires 7
Catania 7
Totale 6.853
Salva come PNG Salva come JPEG
Nome #
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study 128
The Shaggy Aorta Syndrome: an updated review 123
Antecedent ACE-inhibition, inflammatory response, and cardiac surgery associated acute kidney injury 119
Bridging Biology and Society: Molecular Insights into Social Determinants of Vascular Disease 104
Elevati livelli del “marker” tumorale Ca-125 nei pazienti con sindrome nefrosica 101
Risk of Bleeding in Elderly Patients Undergoing Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement 93
Role of a dual glucose-dependent insulinotropic peptide (GIP)/glucagon-like peptide-1 receptor agonist (twincretin) in glycemic control: From pathophysiology to treatment 92
Genetic biomarkers in chronic venous disease 90
Hypoxia-inducible factor stabilizers in end stage kidney disease: “can the promise be kept?” 88
Altered circulating marinobufagenin levels and recurrent intradialytic hypotensive episodes in chronic hemodialysis patients: a pilot, prospective study 88
Ankle-Brachial Index evaluation in totally percutaneous approach vs. femoral artery cutdown for endovascular aortic repair of abdominal aortic aneurysms 87
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 83
#4500 IMPLEMENTATION OF A NEW GENERATION DIGITAL STETHOSCOPE FOR ARTERIOVENOUS FISTULA MONITORING IN HEMODIALYSIS PATIENTS 81
Aortic Aneurysms, Chronic Kidney Disease and Metalloproteinases 81
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 77
Quality of life, clinical outcome, personality and coping in chronic hemodialysis patients 76
Efficacy and Safety of Jotec E-Ventus BX Stent Graft for Iliac Branch Device Procedure: A Retrospective Clinical Study 74
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post-hoc analysis of the ROTATE-3 study 73
An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD) 73
Role of proteinuria in clinical research: For each old-answer, a new key-question 73
A portable easy-to-use triboelectric sensor for arteriovenous fistula monitoring in dialysis patients 72
Evaluation of arteriovenous fistula for hemodialysis with a new generation digital stethoscope: a pilot study 70
LOW CIRCULATING LEVELS OF CARDIO-REGULATORY MIRNAS PREDICT WORSE OUTCOMES IN HEMODIALYSIS PATIENTS 70
Biomarkers and Social Determinants in atherosclerotic Arterial Diseases: A Scoping Review 69
Acquisition of optical coherence tomography angiography metrics during hemodialysis procedures: A pilot study 69
An uncommon presentation of an uncommon nephropathy: the karyomegalic interstitial nephritis 69
Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer 69
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-over Clinical Trial 68
Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients 68
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients 66
Role of metalloproteinases and their inhibitors in the development of abdominal aortic aneurysm: current insights and systematic review of the literature 66
L'insufficienza renale acuta tossico-ischemica 65
Differential activation of signaling pathways involved in cell death, survival and inflammation by radiocontrast media in human renal proximal tubular cells 65
Omics in chronic kidney disease: Focus on prognosis and prediction 65
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease 65
#4524 TRIBOELECTRIC EVALUATION OF ARTERIOVENOUS FISTULA FOR HAEMODIALYSIS: A PILOT STUDY 64
Iron Infusion And Induced Hypophosphatemia: The Role Of FGF2 64
Clinical and Pathological Correlations in Chronic Venous Disease 64
Hyperkalemia in CKD: an overview of available therapeutic strategies 64
Atorvastatin improves the course of ischemic acute renal failure in aging rats 63
Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health 63
Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors 62
The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study 62
Novel biomarkers for cardiovascular risk 62
Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Biomarkers for Cardiovascular Surgery Procedures: A Literature Review 62
Workplace Violence towards Healthcare Workers: An Italian Cross-Sectional Survey 62
A Qualitative Study on the Role of Social Determinants of Health in Patients with Peripheral Artery Disease 61
New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases 61
Nephrosclerosis impacts time trajectory of renal function and outcomes in elderly individuals with chronic kidney disease 59
Social Aspects of Diabetic Foot: A Scoping Review 59
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 58
Association between Inguinal Hernia and Arterial Disease: A Preliminary Report 58
Retarding progression of chronic kidney disease in autosomal dominant polycystic kidney disease with metformin and other therapies: An update of new insights 58
Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease 58
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 57
Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease 57
Insomnia Prevalence among Italian Night-Shift Nurses 57
Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy 57
Development of a Wearable Device for Arteriovenous Fistula Monitoring 56
Can the aggravation of pruritus be a sign of worsening peripheral neuropathy in uremic disease? A clinical and Neurophysiological study 56
Endovenous radiofrequency ablation of tributary veins reflux 56
Anti-renin-angiotensin-system drugs and development of anemia in chronic kidney disease 56
P1422CATHEPSIN-K IS A POWERFUL DIAGNOSTIC BIOMARKER IN PARATHYROIDECTOMIZED DIALYSIS PATIENTS 56
Very low urinary marinobufagenin excretion reflects a high risk of disease progression in non-advanced CKD 55
Role of renal biopsy in the diagnosis and prognosis of acute renal failure 55
Novel biomarkers in cardiovascular surgery 55
Radiographic contrast nephropathy 54
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis 54
Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide-treated human renal proximal tubular cells by alpha-erythropoietin 54
Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients 54
Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects 53
Can Pulsatile Cardiopulmonary Bypass Prevent Perioperative Renal Dysfunction during Myocardial Revascularization in Elderly Patients? 53
Functional chronic venous disease: A systematic review 53
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients 53
Work and the Veins. A Retrospective Analysis of Work Activities in Patients with Chronic Venous Disease 52
Diuretics in renal failure. 52
P1417ALTERED CATHEPSIN-K LEVELS REFLECT SEVERITY OF MINERAL BONE DISEASE AND INFLAMMATION IN CHRONIC HEMODIALYSIS PATIENTS 52
Childhood Obesity: Insight into Kidney Involvement 51
BIOMARKERS FOR PRECISION MEDICINE IN PHLEBOLOGY AND WOUND CARE. A SYSTEMATIC REVIEW 51
Elevate to Alleviate – Evidence Based Vascular Nursing Study 51
New-onset hemodialysis-related headache presenting as migraine aura 50
Vasomotor nephropathy in the elderly 50
Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients 50
Darbepoetin alfa reduces cell death due to radiocontrast media in human renal proximal tubular cells 50
Th17-Gene Expression Profile in Patients with Chronic Venous Disease and Venous Ulcers: Genetic Modulations and Preliminary Clinical Evidence 49
Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications 49
Is erythropoietin always cytoprotective? 49
Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial. 49
Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients 49
OCT angiography metrics predict intradialytic hypotension episodes in chronic hemodialysis patients: a pilot, prospective study 49
Sodium-Glucose Co-transporter-2 Inhibitors and Nephroprotection in Diabetic Patients: More Than a Challenge 49
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 48
Potential Pathogenetic Role of the D313Y Mutation in the GLA Gene in Anderson Fabry Disease: Two Case Reports 48
Can young adult patients with proteinuric IgA nephropathy perform physical exercise? 48
Serum Alkaline Phosphatase Negatively Affects Endothelium-Dependent Vasodilation in Naïve Hypertensive Patients. 48
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale 48
Competitive interaction between smoking and chronic obstructive pulmonary disease for explaining renal function reduction in hypertensive patients 47
The Role of Biofilm In Central Venous Catheter Related Bloodstream Infections: Evidence Based Nursing And Review of The Literature 47
Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile 47
Utility of Blood Flow/Resistance Index Ratio (Qx) as a Marker of Stenosis and Future Thrombotic Events in Native Arteriovenous Fistulas 47
Totale 6.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.094
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 0 0 0 0 0 0 19
2021/2022578 24 8 20 96 32 7 36 142 46 58 100 9
2022/20231.316 391 129 42 109 80 80 20 94 186 67 87 31
2023/2024850 144 105 56 61 55 183 29 56 38 22 42 59
2024/20252.576 370 131 114 113 115 370 69 77 273 181 286 477
2025/20266.550 305 702 934 1.360 604 218 624 391 707 427 144 134
Totale 12.241